POMACIN

Pfizer Inc.

Application Filed: 2010-12-30

Trademark Application Details

Status

606

Dead/Abandoned

ABANDONED - NO STATEMENT OF USE FILED

Research	OneLook Acronym Finder
Serial Number	85207993
Mark Drawing Code	4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form
Attorney Name	Katrina Edge
Attorney Docket Number	T385496
Law Office Assigned	M80
Employee Name	YOUNG, CARRIE SKYE

Timeline

2010-12-30	Application Filed
2011-05-03	Published for Opposition
2011-06-28	Location: INTENT TO USE SECTION
2012-01-30	Abandon
2012-01-30	Status: Dead/Abandoned
2018-07-08	Transaction Date

Trademark Applicants & Owners

Owner:	Pfizer Inc.
Address	235 East 42nd Street New York DE 10017
Legal Entity Type	Corporation
Legal Entity State	DE

Documents

Click the blue "Refresh" button to load certificates, specimines, application, and other documents.

Attorney of Record

KATRINA EDGE
PFIZER INC.
150 E 42ND ST
NEW YORK, NY 10017-5612

Good, Services, and Codes

International Codes:	5
U.S. Codes:	006,018,044,046,051,052

Type Code	Type
GS0051	Veterinary preparations for the prevention or treatment of ocular disorders; oral diseases; central nervous system diseases and disorders, namely central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, encephalitis, epilepsy, Alzheimer's, cerebral palsy, insomnia, seizure disorders; circulatory system diseases and disorders, namely disorders in blood circulation, hypertension, portal hypertension, pulmonary diseases, pulmonary hypertension and heart failure; immunological diseases and disorders, namely autoimmune diseases, immunologic deficiency syndromes; the cardio-vascular system; the respiratory system; musculoskeletal diseases and disorders, namely connective tissue diseases, bone diseases, osteoporosis, spinal diseases, back pain, fractures, sprains, cartilage injuries; the digestive system; genitourinary diseases, namely urological diseases, infertility, sexually transmitted diseases, inflammatory pelvic diseases; and reproductive health diseases and disorders, namely, male and female infertility, ovulation disorders, hormone replacement therapy indicated for the relief of menopause symptoms and the prevention of osteoporosis; veterinary preparations for the treatment or prevention of infectious diseases, obesity, behavioral disorders and inflammatory disorders; veterinary preparations for use in dermatology, oncology, hematology, ophthalmology, and gastroenterology; veterinary preparations, namely, dental preparations, namely a pharmaceutical drug or vaccine for the treatment or prevention of tooth decay, tooth sensitivity, gingivitis, halitosis and periodontal disease; veterinary preparations, namely, nutritional additives to foodstuffs for animals for medical purposes and food supplements; veterinary preparations, namely, pharmaceutical preparations for relieving teething pains and toothaches in companion animals; veterinary parasiticides; veterinary analgesic preparations; veterinary anti-allergen preparations, namely, allergy medications; veterinary preparations, namely, anti-infectives, anti-bacterials, anti-virals, antibiotics, antifungals, anthelmintics, all of the foregoing for treating felines, canines, bovines, porcines, equines, rabbits, poultry, goats and sheep

Type Code

Type

GS0051

Veterinary preparations for the prevention or treatment of ocular disorders; oral diseases; central nervous system diseases and disorders, namely central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, encephalitis, epilepsy, Alzheimer's, cerebral palsy, insomnia, seizure disorders; circulatory system diseases and disorders, namely disorders in blood circulation, hypertension, portal hypertension, pulmonary diseases, pulmonary hypertension and heart failure; immunological diseases and disorders, namely autoimmune diseases, immunologic deficiency syndromes; the cardio-vascular system; the respiratory system; musculoskeletal diseases and disorders, namely connective tissue diseases, bone diseases, osteoporosis, spinal diseases, back pain, fractures, sprains, cartilage injuries; the digestive system; genitourinary diseases, namely urological diseases, infertility, sexually transmitted diseases, inflammatory pelvic diseases; and reproductive health diseases and disorders, namely, male and female infertility, ovulation disorders, hormone replacement therapy indicated for the relief of menopause symptoms and the prevention of osteoporosis; veterinary preparations for the treatment or prevention of infectious diseases, obesity, behavioral disorders and inflammatory disorders; veterinary preparations for use in dermatology, oncology, hematology, ophthalmology, and gastroenterology; veterinary preparations, namely, dental preparations, namely a pharmaceutical drug or vaccine for the treatment or prevention of tooth decay, tooth sensitivity, gingivitis, halitosis and periodontal disease; veterinary preparations, namely, nutritional additives to foodstuffs for animals for medical purposes and food supplements; veterinary preparations, namely, pharmaceutical preparations for relieving teething pains and toothaches in companion animals; veterinary parasiticides; veterinary analgesic preparations; veterinary anti-allergen preparations, namely, allergy medications; veterinary preparations, namely, anti-infectives, anti-bacterials, anti-virals, antibiotics, antifungals, anthelmintics, all of the foregoing for treating felines, canines, bovines, porcines, equines, rabbits, poultry, goats and sheep

Trademark Filing History

Description	Date	Event Coding
NEW APPLICATION ENTERED IN TRAM	2011-01-03	1 NWAP I:Incoming Correspondence
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM	2011-01-07	2 NWOS I:Incoming Correspondence
ASSIGNED TO EXAMINER	2011-03-22	3 DOCK D:Assigned to Examiner
APPROVED FOR PUB - PRINCIPAL REGISTER	2011-03-23	4 CNSA P:
PUBLISHED FOR OPPOSITION	2011-05-03	5 PUBO A:Allowance for Publication
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED	2011-05-03	6 NPUB E:E-Mail
NOA E-MAILED - SOU REQUIRED FROM APPLICANT	2011-06-28	7 NOAM E:E-Mail
ABANDONMENT - NO USE STATEMENT FILED	2012-01-30	8 ABN6 S:
ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED	2012-01-30	9 MAB6 O:Outgoing Correspondence

Similar Marks

Mark Image Registration \| Serial	Company Trademark Application Date
POMACIN 85207993 not registered Dead/Abandoned	Pfizer Inc. 2010-12-30
POMACIN 76132114 not registered Dead/Abandoned	Pfizer Inc. 2000-09-20

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.